Curtis Gale Oltmans, Chief Legal Officer at Fulcrum Therapeutics, Inc. (FULC), sold 3,452 shares at $12.92 ($45K) on 2025-12-15, disclosed to the SEC on 2025-12-17.
Scheduled sale ($45k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ARRY | SELL | 2019-01-29 | $253K | — | Filing → |
| ARRY | SELL | 2019-01-23 | $23K | — | Filing → |
| ARRY | SELL | 2019-01-17 | $712K | — | Filing → |